Implications of nanotechnology for the treatment of cancer: Recent advances

The use of nanoparticles dramatically increases the safety and efficacy of the most common anticancer drugs. The main advantages of nano-drugs and delivery systems based on nano-technology are effective targeting, delayed release, increased half-life, and less systemic toxicity. The use of nano-carriers has led to significant improvements in drug delivery to targets compared with traditional administration of these drugs. In this review, the main tendencies in nano-drug formulations as well as factors limiting their use in clinical settings are discussed. Additionally, the current status of approved nano-drugs for cancer treatment is reviewed.

Automated summary

The use of nanoparticles in anticancer drugs improves safety and efficacy, with advantages such as effective targeting, delayed release, increased half-life, and reduced systemic toxicity. Nano-carriers have shown significant improvements in drug delivery compared to traditional administration, but there are still limitations in their clinical use.